Over 350 Brand-Name Drugs See a Price Increase in 2026

Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...

As Health Care Costs Climb, Stability Matters More Than Ever

As 2026 approaches, employers and employees alike are seeking greater stability in how they pay for health care. While national costs continue to rise, self-funding give employers a level of control over spending and plan design that traditional coverages often lack....